Literature DB >> 6861433

Intraindividual and interindividual variability in 8-methoxypsoralen kinetics and effect in psoriatic patients.

M J Herfst, F A De Wolff.   

Abstract

Our purpose was to investigate the origin of intraindividual variation in comparison with interindividual variation of 8-methoxypsoralen (8-MOP) kinetics in different body fluids. The clinical test in therapy with psoralens and ultraviolet A (PUVA), expressed as the minimal phototoxic dose (MPD), was performed to establish a possible connection between biologic effect and kinetics of 8-MOP. The MPD and 8-MOP kinetics in serum and suction blister fluid (sbf) were determined in 18 psoriatic patients on PUVA therapy in 4 test days spread over a 7-mo period. Evidence showed that interindividual fluctuations are caused by differences in intrinsic clearance (Cl). Interindividual variations are large in comparison with intraindividual variations. A correlation was found among maximal serum concentrations, Cls, MPDs, and concentrations in sbf. In clinical practice the maximal serum concentration, determined in blood samples taken at 1, 2, and 3 hr after 8-MOP ingestion, is indicative of the rate of 8-MOP metabolism and thus of the biologic effect in the patient.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6861433     DOI: 10.1038/clpt.1983.139

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  6 in total

Review 1.  Drug monitoring in nonconventional biological fluids and matrices.

Authors:  S Pichini; I Altieri; P Zuccaro; R Pacifici
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

2.  Spatial distribution of 8-methoxypsoralen penetration into human skin after systemic or topical administration.

Authors:  Marcella Grundmann-Kollmann; Maurizio Podda; Lutz Bräutigam; Katja Hardt-Weinelt; Ralf J Ludwig; Gerd Geisslinger; Roland Kaufmann; Irmgard Tegeder
Journal:  Br J Clin Pharmacol       Date:  2002-11       Impact factor: 4.335

Review 3.  5-Methoxypsoralen. A review of its effects in psoriasis and vitiligo.

Authors:  W McNeely; K L Goa
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics of methoxsalen and other psoralens.

Authors:  F A de Wolff; T V Thomas
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

5.  The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humans.

Authors:  V Billard; P L Gambus; J Barr; C F Minto; L Corash; J W Tessman; J L Stickney; S L Shafer
Journal:  Br J Clin Pharmacol       Date:  1995-10       Impact factor: 4.335

6.  Food-induced increase in bioavailability of 5-methoxypsoralen.

Authors:  H Ehrsson; I Wallin; A M Ros; S Eksborg; M Berg
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.